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ABSTRACT
Osteolytic disease of the bones have a myriad range of aetiology. One rare cause is Gorham’s disease 
or disappearing bone disease. This disease is a diagnosis by exclusion using correlation made with 
clinical presentation, radiological findings and histopathological confirmation. Although many different 
therapies have been advocated, none have been successful in fully controlling this disease. We present a 
case that was detected in a Chinese lady using diagnostic imaging, confirmed with computed tomography 
guided biopsy and successfully treated with joint reconstruction using endoprosthesis. 
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INTRODUCTION
Gorham’s disappearing bone disease is a rare idiopathic disorder characterized by rapid bone destruction. An overview 
of this disorder was reported in 1954 by Gorham and colleagues and subsequently described by Gorham and Stout 
who recognised it as a syndrome in 1955. This disorder does not have any evidence of a malignant, immunologic, 
neuropathic, or infectious component involved in its pathophysiology. This case report aims to highlight a histologically 
studied case of disappearing bone disease in a Chinese woman who had the disease involving multiple joints of the 
lower limbs. 
CASE REPORT
A 41-year-old Chinese woman, presented with a 6 months history of left knee swelling. Except for a past medical 
history of hypertension, she had been previously well. There was no preceding history of trauma or fever. Her left 
knee had become progressively swollen with limited range of movement. Her vital signs were stable. Her left knee 
was swollen, warm and tender. The range of movement was between 10-60 degrees of flexion. Radiograph of her knee 
joints showed bony destruction with sclerosis of the left tibial plateau (Figure 1a), proximal shaft of the left tibia and 
distal third of the left femur. Apart from minimal degenerative changes evidenced by osteophytes, the right knee joint 
was normal. Laboratory tests were all within normal limits. Her haemoglobin level was 14.2g/dL, white blood count 
6.7 x 109/L, serum calcium 2.12mmol/L and ALP 103 IU/L. C-reactive protein levels were <0.4mg/dL and renal 
function test was normal. She was given analgesics and discharged home.
Unfortunately, she came back with a new complaint of recent onset right knee and right hip pain. Upon further 
questioning, the joint pains were not migratory in nature. She had a low grade fever but did not have any features of 
connective tissue disease such as rashes, deformity of her hands, etc. Nevertheless, considering she was a female, a 
provisional diagnosis of connective tissue disorder was entertained. Several radiological and laboratory investigations 
were undertaken. There was no significant abnormality noted in the pelvic x-ray (Figure 1b). However, three months 
later her left knee pain and right hip pain became progressively worse. Serial pelvic radiographs showed bony 
destruction of the head of right femur. Just within one year there was total bone resorption of the head of the right 
femur (Figure 1c). Her serum C-reactive protein was only slightly elevated (30.4mg/dL) and ESR was within normal 
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limits. A differential diagnosis of septic arthritis due to tuberculosis was made. However, blood cultures were 
negative and left knee joint aspirates as well as sputum for AFB were also negative. Serum complement level of 
C3 and C4 were not significantly decreased to suggest an autoimmune aetiology. ANCA and ANF were within 
normal range.
Figure 1: (a) Marked bony destruction of the left proximal tibia noted (white arrow). (b) Pelvic radiograph showing 
a normal head of right femur (black thick arrow). (c) The head of right femur is completely destroyed (black thin 
arrow) within one year of patient presenting with right hip pain. (d) Coronal MPR CT scan showing right THR metal 
prosthesis that had been inserted for the patient to replace the destroyed head of right femur.
As the cause of her rapid osteolysis remained unanswered, bone biopsies of the left knee and right hip were 
performed approximately 1 month later. Histopathological findings of the left knee biopsy were irregular trabeculae 
of lamellar bone with occasional intervening vascularized fibrous tissue (Figure 2a). Foci of granulation and 
vascular proliferation in which capillary type and thicker-walled vessels, many dilated, were seen on high powered 
field in the right femur specimen (Figure 2b). There were also areas of non-viable bone with intervening fibrous 
tissue that exhibited vascular proliferation. There was no evidence of malignancy. The pathologist concluded 
that in the absence of other aetiological factors, features were compatible with Disappearing Bone Disease.
 
Figure 2: Histopathological findings from the bone biopsy. (a) Left tibia (b) Right hip. Foci of granulation and vascular 
proliferation in which capillary type and thicker-walled vessels (white arrows), many dilated, were seen. There were 
also areas of non-viable bone with intervening fibrous tissue (black arrows) that exhibited vascular proliferation. 
There was no evidence of malignancy.
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Six months later, she was planned for an elective left total knee replacement (TKR) due her limited range 
of movement affecting her activities of daily living. Intra-operative findings were hypoplasia and deformity 
of the left lateral femoral condyle. There was extensive bone loss noted in the central and medial aspect of the 
left tibial plateau. Avulsion of the patella tendon was noted and stitched. TKR was done and she was then put 
on knee brace. She was able to ambulate with the aid of a walking frame. Nine months after the knee surgery, 
she complained of worsening right hip pain. Subsequently, a right total hip replacement (THR) was performed 
(Figure 1d). Approximately one month later, she was again warded for the complication of dislocated right 
THR. Closed manual reduction was successful in reducing the dislocation and the patient was discharged well.
      
  
DISCUSSION
Disappearing bone disease is a rare disorder manifested by massive osteolysis associated with vascular endothelial 
proliferation within involved bones (1). It is known by many eponyms among which include Gorham’s syndrome, 
Gorham-Stout Syndrome, Morbus Gorham-Stout Disease, Massive Osteolysis, idiopathic massive osteolysis, 
progressive massive osteolysis, massive Gorham osteolysis, vanishing bone disease and phantom bone disease (2). 
As of date, there are less than 200 cases reported in English literature and mostly it affects men (3). The disease 
may occur at any age, but is common in adolescents and young adults. There is no racial prevalence nor is there any 
evidence that it is hereditary. A history of occasional minor trauma can be found in many patients (4). The aetiology 
of this condition is unknown. Therefore, it is a disease by exclusion of other causes of osteolysis such as neuropathy, 
infection, tumour, trauma (Sudeck’s atrophy), gout, reticuloses and scleroderma (4). As in our patient who presented 
with swelling, the clinical presentation of a patients suffering from vanishing bone disease includes, most frequently, 
pain, functional impairment and swelling of the affected region (1).
The pathophysiology of this poorly understood disease is uncertain and the stimulus causing osteolysis is 
unknown. Nevertheless, in all cases, there is replacement of normal bone by an aggressively expanding but non-
neoplastic vascular tissue similar to a hemangioma or lymphangioma. This proliferating neovascular tissue causes 
massive bone osteolysis. Initially, the bone undergoes resorption, and is replaced by hypervascular fibrous connective 
tissue and angiomatous tissue (1). Although the exact mechanism leading to the massive bone destruction is unknown, 
there has been some research done that suggest interleukin-6 (IL-6) cytokine as a tumoral mediator causing the rapid 
progressive osteolysis of Gorham-Stout disease (6).
Histologically, involved bones show a non-malignant proliferation of thin-walled vessels. This proliferation 
may be capillary, sinusoidal or cavernous type. In the late stage, there is progressive dissolution of 
the bone leading to massive bone loss, with the osseous tissue being replaced by fibrous tissue (3). 
In patients with joint involvement, such as in our patient, Charcot’s arthropathy, septic arthritis and avascular 
necrosis should be considered as differential diagnoses. Radiological imaging and laboratory tests can help in 
narrowing down the diagnosis. Ultimately, in cases where the aetiology is uncertain, a bone biopsy can help shed 
light to make a definitive diagnosis as was done for our patient. 
Most cases report a single bone involvement and multiple sites involvement is rare. Although any part of 
the skeleton can be affected, the disease shows a predilection for maxilla, shoulder girdle, ribs and pelvis (4). The 
disease is usually progressive but may eventually stabilize. Although very rare, there have been isolated cases where 
spontaneous regression has been noted to occur (1).
Apart from skeletal involvement, this disease can also affect the thorax, causing pleural effusion and chylothorax, 
which can have a fatal outcome. There have been many different treatment modalities have been employed for the 
management of chylothorax in patients with Gorham’s disease, including pleurectomy and pleurodesis, thoracic duct 
ligation, and  radiation therapy, interferon therapy, oral clodronate, and bleomycin (3).
In general, major treatment modalities for this phantom bone disease are surgery and radiation therapy. Agents 
that inhibit bone resorption (bisphosphonates, calcitonin) and radiotherapy have been empirically used for treatment 
(3). Surgical options include resection of the lesion and reconstruction using bone grafts or prostheses (4). Radiation 
therapy appears to result in a good clinical outcome with few long-term complications. Fractionated radiotherapy and 
interferon-α2b are advocated as they inhibit angiogenesis and can be potentially beneficial in treating this disease (3). 
Several medical treatments have been advocated, including vitamin D, sodium floride, calcitonin, biphosphanates, 
androgens, interpheron, interleukins, but with little evidence of benefit (6). The disease prognosis remains unpredictable 
and more research is needed to identify an effective treatment for this debilitating condition. 
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